Endometriosis tracer

EP4770684A1Pending Publication Date: 2026-07-08STICHTING RADBOUD UNIVERSITAIR MEDISCH CENT
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
EP · EP
Patent Type
Applications
Current Assignee / Owner
STICHTING RADBOUD UNIVERSITAIR MEDISCH CENT
Filing Date
2024-08-30
Publication Date
2026-07-08

AI Technical Summary

Technical Problem

Current imaging procedures lack the sensitivity and specificity to reliably visualize endometriosis lesions, leading to incomplete surgical removal and high relapse rates.

Method used

A conjugate comprising a FAP targeting ligand and an effector is introduced into a subject to visualize endometriosis lesions, allowing for more accurate detection and treatment.

Benefits of technology

The use of FAP targeting ligands enables non-invasive detection of endometriosis lesions, improving surgical outcomes by ensuring complete removal and reducing the risk of relapse.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 00000025_0000
    Figure 00000025_0000
  • Figure 00000026_0000
    Figure 00000026_0000
  • Figure 00000027_0000
    Figure 00000027_0000
Patent Text Reader

Abstract

The present invention relates to a conjugate comprising a FAP targeting ligand and an effector, for use in the treatment and / or diagnosis of endometriosis, and associated methods and kits.
Need to check novelty before this filing date? Find Prior Art